P. 1 P9. Introducer P10. ) ) 2 P11. 1 P12. polytetrafluoroethylene 1 P13. P14. P15. 1 P16. twiddler syndrome 1 P1. h 141
|
|
|
- やすもり たておか
- 5 years ago
- Views:
Transcription
1 ) ) A 1 ) ) P1. AAI ME P2. DDD MR HOCM 1 P3. middle cardiac vein P4. MRSA P5. ) P P. 1 14:30 15:30 140
2 P. 1 P9. Introducer P10. ) ) 2 P11. 1 P12. polytetrafluoroethylene 1 P13. P14. P15. 1 P16. twiddler syndrome 1 P1. h 141
3 ) ) P1. P19. P20. 1 P21. DDD AF suppression P22. PVAB P23. AF suppression 1 142
4 ) ) B CRT 1 P24. P25. SPECT P26. CRT P2. P2. P29. P30. h ) ) 143
5 ) P31. QRS P32. CRT CSR-CSA ) CRT 2 P33. CRT-D Upgrade 1 P34. CRT 3 P35. MDCT 1 P36. 1 P
6 P3. CRT VVT mode 1 P39. Venoplasty LV 1 P40. 1 ) ) P41. Enhanced activity of sarcolemmal Na + HCO 3 cotransporter in cardiac hypertrophy P42. KCNH2 S641F) QT P43. M P T 145
7 P45. Kyoto Model EAD ) ) P46. very low frequency P4. CPAP P4. Nasal CPAP P49. BNP P50. ST QRS ST P51. T-wave alternance P
8 P53. P54. 2 P55. AF suppressionafs P56. P5. ) ) P5. Brugada P59. P60. P61. Brugada P62. 14
9 ) ) C 1 ) ) P63. P64. 1 P65. V 1 ) QS WPW 3 P66. Slow-fast 1 fast-slow 1 P6. P6. Koch 2nd report P69. Irregular AVNRT sub-form 14
10 P0. P1. P2. HOT Hybrid therapy P3. I 1 P4. Cleveland Clinic Foundation, Pacing and Electrophysiology, Center for Atrial Fibrillation P5. Isthmus dependent atrial flutter P6. ) ) 149
11 2 ) ) P. 1 P. 1 P9. 1 P0. CARTO activation map 2 2 P1. Activation mapping Paced activation sequence mapping P2. Scar Macro reentrant Atrial Tachycardia Atrial Flutter 2 P3. Maze 1 150
12 P4. Mustard 14 1 P5. P6. point-by-point ) ) 3 P. CFAE Continuous Fractionated Atrial Electrogram P. ) P9. Double Lasso P90. STa 151
13 ) ) P91. P92. PVI) P P P94. TdP trigger 1 P95. CARTO system focal 1 P96. 2 P9. Electroanatomical mapping system 2 P9. electrical storm 1 P99. ) 152
14 P100. Atrial switch operation, ASD closure direct suture), VSD closure Patch) 1 P P102. CRT 1 P103. Electrical storm Brugada P104. Electro-anatomical precedence mapping EAP) P105. bail-out P106. ) ) 4 P
15 ) ) P10. K Tdp P
16 ) ) D 1 P110. P P112. P113. P114. Disopyramide, Cibenzoline Aprindine P115. ) ) 155
17 2 ) ) P116. Cibenzoline P11. Brugada P11. P119. P120. Nifekalant P121. Tissue Velocity Image intraventricular conduction study 3 P
18 P123. WPW 1 P P125. Post-Pacing IntervalPPI) WPW P WPW 1 P12. P12. Electroanatomical mapping system ) ) 4 P
19 ) ) P130. P131. P P133. P134. C P P136. P13. P13. 15
20 P139. P140. ) 5 ) P P142. P143. P144. AED P145. ICD 1 P146. electrical storm 1 Magdy Algowhary 159
21 ) ) P14. P14. MRI P149. ARVC P150. Pilsicainide Brugada incessant VT P151. Torsades de pointes TdP) 2 P152. conus branch coved-type ST Brugada P153. P154. Brugada 1 P155. h 160
22 P156. P15. P15. QRS 1 P159. QT Torsade de pointes P160. P161. TdP 2:1 1 P ) ) 161
23 ) ) E ICD-1 ) ) P163. ICD) 1 P P165. P166. ICM ICD P16. ICDGEM DR 221 P16. CRT ICD P169. ICD 3 P10. ICD 2 162
24 ICD-2 P11. ICD P12. P13. P14. Integrated bipolar ICD lead P15. ICD P16. ICD P1. ICD electrical storm P1. ICD Brugada P19. Reconfimation 1 h ) ) 163
25 ) ) P10. ICD) P11. ICD Brugada 1 P12. Electrical storm Brugada 1 164
26 ) ) F P13. P14. P15. P16. 5% TRM645 P1. P1. ) ) 165
27 ) ) P19. Brugada Mini Body Surface Mapping P190. Brugada P P192. EV-50 P193. CadioMobi EV P194. QT QT P195. WPW P196. / 166
28 P19. T-wave variation P19. Efficacy of Immediate Response to Pre-hospital Arrhythmic Events by the Transtelephonic Electrocardiogram Network P199. R P200. ROC P201. U Initial Terminal U Inversion ) ) P202. QT ) P203. U P204. Brugada 1 16
22...J.e.A.u.Q01-07_.O.t
113:00~14:00 The Value of Electrogram Analyses in Defining Arrhythmia Mechanisms-Implications for Catheter Ablation Melvin M. Scheinman University of California San Francisco, USA 1 112:00~13:00 Next Generation
098青沼班DGfinal修正0506.indd
1 2011 Brugada QT 2005 2006 2007 Brugada Brugada 20 QT 70 2007 Brugada ICD ICD 5 2 QT Brugada 2012 QT QT QT Brugada Brugada 5 AHA/ACC ESC I II III A B C I II IIa IIb III A B C QT long QT syndrome LQTS
抄 録 第 13 回日本小児心電学研究会 PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 25 NO. 5 ( ) VSD Brugada 1 Brugada Brugada = mm 5mm Qp/Q
抄 録 第 13 回日本小児心電学研究会 PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 25 NO. 5 (732 745) 2008 11 15 1 VSDBrugada 1 Brugada Brugada = 2 7 11 8mm 5mm Qp/Qs = 4.20 LR shunt = 80Pp/Ps = 0.93 Pp/Ps = 0.60 Rp =
GL_大江班.indd
QT QT QT QT Brugada Brugada Brugada Brugada Brugada Brugada QT QTQTc Torsade de pointes T-wave alternans Notched T wave in leads Circulation Journal Vol. 71, Suppl. IV, 2007 1257 TdP QT Na + ICD QT QT
I PD-I-3 VA ICD 2006 NYHA ~ LVEF 35% a ICD SCD-HeFT ICD MADIT- ICD a CABG-Patch ICD EF b MADITø MADIT- MUSTT EPS EPS 19 EPS 5/19 VA PD-I-4 Holter LP f
J Arrhythmia Vol 23 (Suppl) 2007 PD-I-1 OACIS 95% 6.4 (1.5 27.8 4.3 (1.0 18.5), 0.2 (0.05 0.93), respectively MADIT LVEF 30% 192 2.0 12.4% 24 3.1% MADIT 12.1% p=.001), ICD direct PCI OACIS (Osaka Acute
<FEFF F30D5309A30ED30AF309930E930E0005F E E C83DD004C8A C0018DF38000DD2E >
5 AFEEPVI 2010 1 2012 2 161 EEPVI ablation 5 3 mapping EnSite system St.Jude medical 5 3 ablation AF 5 3 roof line blockline AF 2 CFAE ablation EPS 237 ms 376 ms Mapping 5 activation map 3 post pacing
<91E F193FA967B8F7A8AC28AED8A7789EF8BE38F42926E95FB89EF5F D834F F57315F E696E6464>
8:00 A A1 B B1 2F C B5 6 7 9:00 8:25~8: 8:~9: YIA 8:~9:18 1 8:~9:18 1 10:00 9:18~9:58 2 9:18~9:58 10:10~11:00 11:00 11:00~11:50 12:00 11:50~12:00 YIA 13:00 12:10~13:00 1 24 12:10~13:00 12:10~13:00 2 13:10~14:
untitled
RR QT V1 V2 V3 avr V4 avl V5 avf V6 V1 V2 V3 avr avl avf V4 V5 V6 Torsades de pointes () PVC ( ) late potentials T-wave alternans QT dispersion () 3 (QTDLPTWA) TWA 56 max Valt : 8.8 µv (in Z lead)
GL_小川(聡)班_D.indd
J-RHYTHM Pill-in-the-pocket Up-stream Circulation Journal Vol. 72, Suppl. IV, 2008 1639 Sicilian GambitSicilian Gambit CAST Sicilian Gambit Sicilian Gambit Sicilian Gambit Sicilian Gambit CD-ROM ACC/AHA/ESC
1315 (15)
(14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide
CSRレポート2930
CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT 2009 15 8 14 34 39 5 85 CSR REPORT 2009 CSR REPORT 2009 CSR REPORT
PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 24 NO. 5 ( ) Electrophysiological Studies and Radiofrequency Catheter Ablation before Total Cavo-p
PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 24 NO. 5 (620 627) Electrophysiological Studies and Radiofrequency Catheter Ablation before Total Cavo-pulmonary Connection in Patients with Complex Congenital
24...J.e.A.u.Q _.O.t
EnSitescar breakthrough1 54 RFCA ATCARTO mapping focal AT focus CARTO mapping 2 RFCA EnSite mapping Scar2 Scar breakthrough Scar mapping Scar Exit ATPHis 1 mapping 12 His delayed potential AT ATP ATP delayed
V. 7 1 ICD ICD F00 F99 2 ICD G40 3 1 1. 2. 3. 4. 2 1. 2. 3. 4. 3 1. 2. 3. 4 1. 2. 3. 4. 5 1. 2. 3. 4. 6 1. 2. 3. 4. 5. 6. 7 1. 2. 3. 4. 5. 8 1. 2. 3. 9 1. 2. 3. 4..... 10 1.... 2. 3. 4..... 5. 6. 7.
35 40mmHg PaCO2 40mmHg 35mmHg CO2 PETCO2 CO2 CO2 10mmHg CPR CO2 10mmHg ROSC() CO mmHg ROSC return of spontaneous circulation ROSC 17mmHg ROSC 20
2010 ACLS Circulation Nov.2,2010 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care p640-p767 2010BLS 2010ACLS BLS Circulation, Nov2.2010 2010
1 239 1 1 1 1 1 50 50 2 2 2 1 J1 G 2 20 50 J L AF 2 Y B 2 1 0 20 25 50 3 20 2 50 1 20 50 2 1 1 5 111 115 5 11 11 1 1 5 5 5 1 5 1 5 211 215 2 2 3 3 2 1 5 50 0 50 5 115 2 2 00 5 2 2 252 0 0 1 1 150 13 0
001-009.Q.O.t..
O1 O21 O31 O4Auto PVARP1 O51 ME O6Screw-inLead O7 JA CE JA JA O8 O9 O10 O11 O127 O13 ME O14 O15PMTVT1 O16 O17120msecQRS150msec O18Narrow QRS O19ICD CRT-D CRT-D O20Tl O21Super Responder O22 1 O231 O24LV
a 1) 2) IVUS 3)1 7 1) 2) 3) 4) a)134 )12 c)23 d)4 )1~4 c (18 p95) 8 1) 7.5MHz 2) 4 ( ) 3) 4) a)134 )12 c)23 d)4 )1~4 d 9 1) - 2) - 3) - DDR 4)
H18 http://plaza.umin.ac.jp/~wiki/cgi-in/ 1 1) 2) 3) 4) a)134 )12 c)23 d)4 )1~4 4 = = (18 p47) 3 A~D a~ 1)A- 2)B- 3)C- 4)D- a)134 )12 c)23 d)4 )1~4 18 3 4 a~ 1) - 2) - ( ) 3) - 4) - a)134 )12 c)23 d)4
HEART'S Original A case of Brugada syndrome with a high defibrillation threshold in which defibrillation was successful by Active Can off defibrillation Keisuke Kawachi, Yukei Higashi, Yuuki Honda, Kouhei
”RŠœ15-3 #50 ‘¬’X 4“Z+
15 3 45 57 2000 QOL 1950 Cardiac Arrhythmia Suppression Trial 10 WPW 1 10 1990 1996 409-3898 1110 2000 5 23 2000 6 2 4 46 2 2 3 2 1 1 3 3 40 1 10 6 12 Cardiac Arrhythmia Suppression Trial CAST 4 1 3 CAST
21...J.e.A.u.Q07_28_.v...O....
1 7:30~8:25 NavX Atrial Inflammation Pathway and Remodeling: Lessons from Catheter Ablation of Atrial Fibrillation Shih-Ann Chen Taipei Veterans General Hospital, Taiwan St. Jude medical, International
02 CSR REPORT 09
02 CSR REPORT 09 CSR REPORT 09 03 04 CSR REPORT 09 CSR REPORT 09 05 06 CSR REPORT 09 REPORT 01 CSR REPORT 09 07 REPORT 02 08 CSR REPORT 09 REPORT 03 CSR REPORT 09 09 MESSAGE 10 CSR REPORT 09 MESSAGE CSR
METs WPW QT LQTS 9Brugada 0 METs 30 Circulation Journal Vol. 67, Suppl. IV,
2002002 Guidelines for Exercise Eligibility at Schools, Work-Sites, and Sports in Patients with Heart Diseases (JCS 2003) JR 2 3 2 3 2 2 3 2 2 3 Circulation Journal Vol. 67, Suppl. IV, 2003 309 2002002
Microsoft Word - 01マニュアル・入稿原稿p1-112.doc
4 54 55 56 ( ( 1994 1st stage 2nd stage 2012 57 / 58 365 46.6 120 365 40.4 120 13.0 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 4 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97
59
58 17 Productivity and CSR BNP 1 2 3 59 60 61 62 1 1 2 3 BMI 4 10 63 5 6 4 7 B BNP 8 1 64 9 2 10 11 1 12 2 65 13 3 14 4 1 15 IT 16 17 66 18 2 19 20 21 67 22 23 IT 40 24 YRP 25 68 26 30 50 27 28 29 MY 69
9BBH3A8_P0000
02 Yamaha CSR Report 2007 03 Yamaha CSR Report 2007 04 Yamaha CSR Report 2007 Yamaha CSR Report 2007 05 06 Yamaha CSR Report 2007 Yamaha CSR Report 2007 07 08 Yamaha CSR Report 2007 09 Yamaha CSR Report
<91E F193FA967B8F7A8AC28AED8A7789EF8BE38F42926E95FB89EF5F D834F F57315F E696E6464>
113 2,000 3,000 1,000-1 - YIA Case Report AwardCRA - 2 - 1 2 3 4 5 6 7 8 9 10 11-3 - DVD - 4 - 32 1 10:1011:00 AA1 2 11:0011:50 AA1-5 - 1 12:1013:00 AA1 2 12:1013:00 CB567 3 12:1013:00 DA2 / 4 12:1013:00
埼玉29.indb
16 Symposium 29 WPW 1 1 1 1 1 78 PSVT 4 cibenzoline 200mg, verapamil 80mg 2 OMI #7 100 X 51% HbA 1c 5.9% 12 1A 55/ V 1,2 Q 1B 116/ narrow QRS tachycardia av F V 1 P LVEDD/LVESD 55/38mm EF 58 PSVT RV His
<FEFF F30D5309A30ED30AF309930E930E0005F E E C83DD004C8A C0018DF38000DD2E >
41 32 63.7 7.5 CARTO ipv 75 35 2 40 Carto3 5V Thermocool 37 ipv 45 45 ipv 36 ipv 44 9 ipv 11 12 31 76 ipv 34/62 ipv 553/20 ipv 15 P 0.028 5V capture block 2 43 57 32 43 3 7 10 31 P 0.05 6 3 50 5 7 6 AM
改訂にあたって Sicilian Gambit J-RHYTHM Ⅰ 序文 CAST Na Vaughan Williams Sicilian Gambit Sicilian Gambit CD-ROM ガイドライン作成の基本方針. Sicilian Gambit... 2
循環器病の診断と治療に関するガイドライン (2008 年度合同研究班報告 ) ダイジェスト版 不整脈薬物治療に関するガイドライン (2009 年改訂版 ) Guidelines for Drug Treatment of Arrhythmias(JCS 2009) 目 次 Sicilian Gambit ( 無断転載を禁ずる ) 1 改訂にあたって Sicilian Gambit J-RHYTHM
CAST Na Vaughan Williams Sicilian Gambit 1996 Sicilian Gambit CD-ROM CD-ROM J-GAMBIT 1Sicilian Gambit CD-ROM
20022003 Guidelines for Drug Treatment of Arrhythmias (JCS 2004) a 1Sicilian Gambit 2J-GAMBIT 3 1 2 3 4 5 6 7 8 9 Circulation Journal Vol. 68, Suppl. IV, 2004 1055 20022003 20 CAST Na Vaughan Williams
老人性不整脈
資料 : QOL CHADS NOAC はじめに common disease 高齢者の不整脈の頻度, AF AVB RBBB LBBB Cardiovascular Health Study, 137 表 1 Outpatient Atarashi Cardiovascular Health Study Monolio No F M Ectopic beats Supraventricular.
2 CSR -
20312-1819 2 CSR - 3 1 2 3 ( ) 4 - A 5 B C 5. 6 7 8 9 8. - 9. - 58 9 8 25 16, 7 5 2,500 ( ) 0751,920 07125,2000815,700 10 11 10. - - 12 13 - - 14 13. - - 15 1 61 171228 1843 16F 1 80 25 55 ( 3-21-5 http://akan-nt.or.jp
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
01 DAITO GROUP CSR Report 2014
DAITO GROUP CSR Report 2014 01 DAITO GROUP CSR Report 2014 DAITO GROUP CSR Report 2014 02 DAITO GROUP CSR Report 2014 03 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 DAITO GROUP CSR Report 2014
14 00 14 50 3DO3-1 DO3-5 DO3-1 DO3-2 DO3-3 DO3-4 DO3-5 1 1 2 3 3 3 3 3 3 3 1.2. 3. 15 1 2 3 1. 2. 3. 1, 2 2, 3 1, 2 1. 2. JSEPTIC 3. ICU 1 2 1.2. 医 一
第 1 日 目 第 1 日 目 (2 月 9 日 ) 一 演 題 医 師 部 門 演 第 6 会 場 ホテル 日 航 東 京 3F レインボーテラス 9 00 9 50 1 DO1-1 DO1-5 DO1-1 DO1-2 DO1-3 DO1-4 DO1-5 Presepsin LPS PGC-1 1 2 3 2 3 1 1. 2.3. Critical illness polyneuropathy
ワタベウェディング株式会社
1 2 3 4 140,000 100,000 60,000 20,000 0 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 5 6 71 2 13 14 7 8 9 10 11 12 1 2 2 point 1 point 2 1 1 3 point 3 4 4 5 6 point 4 point 5 point 6 13 14 15 16 point 17
p01.qxd
2 s 1 1 2 6 2 POINT 23 23 32 15 3 4 s 1 3 2 4 6 2 7003800 1600 1200 45 5 3 11 POINT 2 7003800 7 11 7003800 8 12 9 10 POINT 2003 5 s 45700 3800 5 6 s3 1 POINT POINT 45 2700 3800 7 s 5 8 s3 1 POINT POINT
untitled
1 2 3 4 5 6 7 Point 60,000 50,000 40,000 30,000 20,000 10,000 0 29,979 41,972 31,726 45,468 35,837 37,251 24,000 20,000 16,000 12,000 8,000 4,000 0 16,795 22,071 20,378 14 13 12 11 10 0 12.19 12.43 12.40
![[商品カタログ]ゼンリン電子地図帳Ｚｉ16](/thumbs/48/24409875.jpg "[商品カタログ]ゼンリン電子地図帳Ｚｉ16")
-- 0 500 1000 1500 2000 2500 3000 () 0% 20% 40% 60%23 47.5% 16.0% 26.8% 27.6% 10,000 -- 350 322 300 286 250 200 150 100 50 0 20 21 22 23 24 25 26 27 28 29 -- ) 300 280 260 240 163,558 165,000 160,000
株主通信：第18期 中間
19 01 02 03 04 290,826 342,459 1,250,678 276,387 601,695 2,128,760 31,096 114,946 193,064 45,455 18,478 10,590 199,810 22,785 2,494 3,400,763 284,979 319,372 1,197,774 422,502 513,081 2,133,357 25,023
1003shinseihin.pdf
1 1 1 2 2 3 4 4 P.14 2 P.5 3 P.620 6 7 8 9 10 11 13 14 18 20 00 P.21 1 1 2 3 4 5 2 6 P7 P14 P13 P11 P14 P13 P11 3 P13 7 8 9 10 Point! Point! 11 12 13 14 Point! Point! 15 16 17 18 19 Point! Point! 20 21
株主通信 第16 期 報告書
10 15 01 02 1 2 3 03 04 4 05 06 5 153,476 232,822 6,962 19,799 133,362 276,221 344,360 440,112 412,477 846,445 164,935 422,265 1,433,645 26,694 336,206 935,497 352,675 451,321 1,739,493 30,593 48,894 153,612
ヤフー株式会社 株主通信VOL.16
01 260,602264,402 122,795125,595 64,84366,493 107110 120,260123,060 0 500 300 400 200 100 700 600 800 39.8% 23.7% 36.6% 26.6% 21.1% 52.4% 545 700 0 50 200 150 100 250 300 350 312 276 151 171 02 03 04 POINT
endo.PDF
MAP 18 19 20 21 3 1173 MAP 22 700800 106 3000 23 24 59 1984 358 358 399 25 12 8 1996 3 39 24 20 10 1998 9,000 1,400 5,200 250 12 26 4 1996 156 1.3 1990 27 28 29 8 606 290 250 30 11 24 8 1779 31 22 42 9
Y/.{../01-01
20022003 Guidelines for Drug Treatment of Arrhythmias (JCS 2004) a 1Sicilian Gambit 2J-GAMBIT 3 1 2 3 4 5 6 7 8 9 1 2 3 4 5 Circulation Journal Vol. 68, Suppl. IV, 2004 981 20022003 20 CAST Na Vaughan
Microsoft PowerPoint - 201409_秀英体の取組み素材（予稿集）.ppt
1 2 3 4 5 6 7 8 9 10 11 No Image No Image 12 13 14 15 16 17 18 19 20 21 22 23 No Image No Image No Image No Image 24 No Image No Image No Image No Image 25 No Image No Image No Image No Image 26 27 28
0717_Smile再入稿.indd
Point 1 Point 2 Point 3 2 2013 3 after report 4 2013 5 6 2013 7 8 2013 9 10 2013 11 12 2013 13 Menu1 Menu3 Menu2 14 2013 15 Menu4 Menu5 Menu7 0.9g Menu6 Menu10 0.8g 11 Menu11 Menu8 Menu9 16 2013 17 18
1 z q w e r t y x c q w 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 R R 32 33 34 35 36 MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR
<4D F736F F D2095BD90AC E937890B68A888F4B8AB E397C394EF82CC93AE8CFC82C98AD682B782E992B28DB895AA90CD2E646F6378>
28 3 IT 1,124 1,414 9,986 1,205 247 2 6,663 6,802 3 4,155 ICD-10 p.2 26 3 4,155 1,124 10 3,628 10.62% 10 31.29%30.75%15.62% 36.31% 29.88%20.94% 928 692 412 205 6,127 4,971 3,246 2,291 1,968 1,658 35.77
![.V...z.\](/thumbs/40/20575037.jpg ".V...z.\")
Ⅰ-A ICD 頻回作動した Brugada 症候群に対して Quinidine で VF 抑制に著効した一例 京都大学医学部附属病院循環器内科 八幡光彦 早野護 加藤義紘 土井孝浩 静田聡 症例は 36 歳男性 父親が 34 歳で睡眠中に突然死されている患者で, 夜間から早朝にかけて の睡眠中の下
Ⅰ-A ICD 頻回作動した Brugada 症候群に対して Quinidine で VF 抑制に著効した一例 京都大学医学部附属病院循環器内科 八幡光彦 早野護 加藤義紘 土井孝浩 静田聡 症例は 36 歳男性 父親が 34 歳で睡眠中に突然死されている患者で, 夜間から早朝にかけて の睡眠中の下顎呼吸, 痙攣, 意識消失発作に対して近医入院となったが, てんかんと診断さ れた その後健康診断で心電図異常が指摘され,Brugada
無印良品のスキンケア
2 3 4 5 P.22 P.10 P.18 P.14 P.24 Na 6 7 P.10 P.22 P.14 P.18 P.24 8 9 1701172 1,400 1701189 1,000 1081267 1,600 1701257 2,600 1125923 450 1081250 1,800 1125916 650 1081144 1,800 1081229 1,500 Na 1701240
untitled
22 23 3 1...1 1...1 2...2 3...3 4...4 2...5 1...5 2...8 3...9 1...9 2... 15 3... 17 4 US&R... 19 5 US&R... 22 6 US&R... 24 7... 26 4... 27 1... 27 2... 28 1... 28 2... 29 3... 32 4... 35 5... 37 3...
1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%